Canada markets closed

Sensus Healthcare, Inc. (SRTS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.25000.0000 (0.00%)
At close: 04:00PM EDT
3.2500 0.00 (0.00%)
After hours: 04:00PM EDT

Sensus Healthcare, Inc.

851 Broken Sound Parkway NW
Suite 215
Boca Raton, FL 33487
United States
561 922 5808
https://sensushealthcare.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees35

Key Executives

NameTitlePayExercisedYear Born
Mr. Joseph C. SardanoCo-Founder, Chairman & CEO754.43kN/A1953
Mr. Michael J. SardanoPresident, General Counsel, Corporate Secretary & Director404.74kN/A1989
Mr. Javier RampollaChief Financial Officer439.14kN/A1973
Ms. Magdalena MartinezChief Operating OfficerN/AN/A1990
Mr. Emiliano SosaChief Technology OfficerN/AN/A1978
Ms. Stephanie TiptonVice President of MarketingN/AN/AN/A
Dr. Mark S. NestorMedical Director & Member of Medical Advisory BoardN/AN/AN/A
Dr. Clay Jefferies CockerellClinical Director & Member of Medical Advisory BoardN/AN/A1957
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Corporate Governance

Sensus Healthcare, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.